Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TNXPTNXP
4 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TONIX PHARMACEUTICALS HLDG C

GOLDMAN SACHS GROUP INC holds 98,356 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $1.3M as of 2026-Q2. The position was increased (+85.4% shares). TNXP represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.3M

Current Shares

98,356

Total Value Change

+$947,659

Total Shares Change

+85,634

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
98,356
+85.4%
$1.3M0.0%$12.76
39
2026-Q1
Increased
53,055
+97.9%
$729,5060.0%$13.94
40
2025-Q4
Increased
26,808
+110.7%
$418,7410.0%$15.82
39
2025-Q3
New
12,722
-
$307,3640.0%$24.76
36

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used